Brazil ANVISA Regulatory Reliance: June 2024 Update to IN 290/2024 Streamlines Class III/IV Device Review

Brazil's ANVISA has updated its review process for the regulatory reliance pathway under IN 290/2024. As of mid-June 2024, instead of rejecting submissions with minor issues, the agency will now issue requirement notices, allowing manufacturers to amend their applications. This episode explains how this change de-risks the submission process for Class III and IV medical devices that rely on approvals from Australia, Canada, the U.S., or Japan, making the pathway more efficient and predictable. Key Questions: - What is Brazil's new regulatory reliance pathway under IN 290/2024? - How has ANVISA's review process for reliance submissions changed as of June 2024? - Why is this change significant for manufacturers of Class III and IV medical devices? - What were the risks of the reliance pathway before this update? - How does the new process of issuing requirement notices reduce submission risk? - Which foreign regulatory approvals are recognized by ANVISA for this pathway? - What practical steps should your regulatory team take to prepare a successful reliance submission? - How can you ensure your submission avoids triggering a requirement notice from ANVISA? Sources: - https://www.emergobyul.com/news/regulatory-reliance-authorizations-brazils-revised-anvisa-process-june-2026 - https://www.emergobyul.com/news/anvisa-updates-hospitalar-2026-attendees-about-regulatory-reliance How Pure Global can help: Pure Global provides end-to-end regulatory consulting for MedTech and IVD companies, simplifying access to over 30 global markets, including Brazil. Our experts can help you develop an efficient regulatory strategy for the ANVISA reliance pathway, manage the technical dossier preparation, and act as your local representative to handle all communications with the agency, including responding to requirement notices. We combine local expertise with advanced AI to accelerate your submission and ensure compliance. For help with your market access strategy, contact us at [email protected] or visit https://pureglobal.com. Explore our free AI tools and global device database at https://pureglobal.ai.